Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43146 (
tumour suppressor
)
5,935
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Inactivation of the
tumour suppressor
gene lethal(2) giant larvae (D-lgl) of Drosophila leads to malignant transformation of the presumptive adult optic centers in the larval brain and tumours of the imaginal discs. These malignancies result from the disorganization of a cytoskeletal network in which the D-LGL protein participates. Here we describe the isolation of a cDNA encoding the human homologue to the D-lgl gene designated as
hugl
. The
hugl
cDNA detects a locus spanning at least 25 kilobases (kb) in human chromosome band 17p11.2-12, which is centromeric to the p53 gene and recognizes a 4.5 kb RNA transcript. The
hugl
gene is expressed in brain, kidney and muscle but is barely seen in heart and placenta. Sequence analysis of the
hugl
cDNA demonstrates a long open reading frame, which has the potential to encode a protein of 1057 amino acids with a predicted molecular weight of 115 kDaltons (kD). To further substantiate and identify the
HUGL
protein, we have prepared polyclonal rabbit antibodies against synthetic peptides corresponding to the amino and carboxyl termini of the conceptual translation product of the
hugl
gene. The affinity-purified anti-
HUGL
antibodies recognize a single protein with an apparent molecular weight of approximately 115 kD. Similar to the Drosophila protein,
HUGL
is part of a cytoskeletal network and, is associated with nonmuscle myosin II heavy chain and a kinase that specifically phosphorylates
HUGL
at serine residues.
...
PMID:A human homologue of the Drosophila tumour suppressor gene l(2)gl maps to 17p11.2-12 and codes for a cytoskeletal protein that associates with nonmuscle myosin II heavy chain. 754 63
Drosophila lethal giant larvae: (lgl), discs large (dlg) and scribble (scrib) are
tumour suppressor
genes acting in a common pathway, whose loss of function leads to disruption of cell polarity and tissue architecture, uncontrolled proliferation and growth of neoplastic lesions. Mammalian homologues of these genes are highly conserved and evidence is emerging concerning their role in cell proliferation control and tumorigenesis in humans. Here we investigate the functional conservation between Drosophila lethal giant larvae and its human homologue
Hugl-1
(Llgl1). We first show that
Hugl-1
is lost in human solid malignancies, supporting its role as a
tumour suppressor
in humans.
Hugl-1
expression in homozygous lgl Drosophila mutants is able to rescue larval lethality; imaginal tissues do not show any neoplastic features, with Dlg and Scrib exhibiting the correct localization; animals undergo a complete metamorphosis and hatch as viable adults. These data demonstrate that
Hugl-1
can act as a
tumour suppressor
in Drosophila and thus is the functional homologue of lgl. Furthermore, our data suggest that the genetic pathway including the tumour suppressors lgl, dlg and scrib may be conserved in mammals, since human scrib and mammalian dlg can also rescue their respective Drosophila mutations. Our results highlight the usefulness of fruit fly as a model system for investigating in vivo the mechanisms linking loss of cell polarity and cell proliferation control in human cancers.
...
PMID:The human protein Hugl-1 substitutes for Drosophila lethal giant larvae tumour suppressor function in vivo. 1546 49
The human gene, human giant larvae (
Hugl-1
/Llg1/Lgl1) has significant homology to the Drosophila
tumour suppressor
gene lethal(2)giant larvae (lgl). The lgl gene codes for a cortical cytoskeleton protein, Lgl, that binds Myosin II and is involved in maintaining cell polarity and epithelial integrity. The human protein,
Hugl-1
contains several conserved functional domains found in Lgl, suggesting that these proteins may have closely related functions. Whether loss of Hugl expression plays a role in human tumorigenesis has so far not been extensively investigated. Thus, we evaluated tumour tissues from 94 patients undergoing surgery for colorectal cancer (CRC) for loss of
Hugl-1
transcription and compared our findings with the clinical data from each of these patients. We found that
Hugl-1
was lost in 75% of tumour samples and these losses were associated with advanced stage and particularly with lymph node metastases. Reduced
Hugl-1
expression during the adenoma-carcinoma sequence occurring as early as in colorectal adenomas was detected by both immunohistochemical and reverse transcription-polymerase chain reaction analysis. Functional assays with ecdysone-inducible cell lines revealed that
Hugl-1
expression increased cell adhesion and decreased cell migration. Our studies thus indicate that downregulation of
Hugl-1
contributes to CRC progression.
...
PMID:Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer. 1573 78
The proper function of the Scribble
tumour suppressor
complex is dependent upon the correct localisation of its components. Previously we observed dynamic relocalisation of the hDlg component under conditions of osmotic stress. We now show that the other two components of the complex, hScrib and
Hugl-1
display similar patterns of expression. We demonstrate, by shRNA ablation of hScrib expression, that hDlg and
Hugl-1
are in part dependent upon hScrib for their correct localization. However under conditions of osmotic stress this apparent dependency no longer exists: hDlg and
Hugl-1
localise to cell membranes independently of hScrib. We also demonstrate an interaction between the three components of the hScrib complex and the tSNARE syntaxin 4, and show that correct localization of the Scrib complex is in part tSNARE dependent. This is the first detailed analysis of the co-localisation and function of the hScrib complex in mammalian cells and demonstrates a direct link between the control of the hScrib complex and vesicle transport pathways.
...
PMID:Regulation of the hDlg/hScrib/Hugl-1 tumour suppressor complex. 1879 35